Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD

The phosphaturic hormone FGF23 is elevated in chronic kidney disease (CKD). The risk of premature death is substantially higher in the CKD patient population, with cardiovascular disease (CVD) as the leading mortality cause at all stages of CKD. Elevated FGF23 in CKD has been associated with increas...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:JCI Insight
Egile Nagusiak: Clinkenbeard, Erica L., Noonan, Megan L., Thomas, Joseph C., Ni, Pu, Hum, Julia M., Aref, Mohammad, Swallow, Elizabeth A., Moe, Sharon M., Allen, Matthew R., White, Kenneth E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478421/
https://ncbi.nlm.nih.gov/pubmed/30830862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.123817
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak